2014
IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection.
Soltys J, Knight J, Scharf E, Pitt D, Mao-Draayer Y. IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection. American Journal Of Translational Research 2014, 6: 312-9. PMID: 24936223, PMCID: PMC4058312.Peer-Reviewed Original ResearchT cellsMultiple sclerosisNeurotrophin receptorActive demyelinating lesionsNeurotrophic factor expressionCytokine expression patternsHigh-affinity receptor 1Mechanism of actionDemyelinating lesionsMS pathogenesisRRMS patientsNeurotrophin productionNeuroprotective effectsNeurotrophin expressionNeuroprotective capabilitiesStem/progenitor cell survivalProgenitor cell survivalDisease pathogenesisReceptor 1Factor expressionIFNPotent inducerSpecific cell populationsCell populationsSclerosis
2011
Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis
Boster A, Bartoszek MP, O’Connell C, Pitt D, Racke M. Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis. Therapeutic Advances In Neurological Disorders 2011, 4: 319-332. PMID: 22010043, PMCID: PMC3187678, DOI: 10.1177/1756285611422108.Peer-Reviewed Original Research